Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβ

Peng Xiao(Jilin University), Yong He(State Council of the People's Republic of China), Heming Sun(Jilin University), Robim M. Rodrigues(Vrije Universiteit Brussel), Gang Ren, Xiaogang Xiang(National Institutes of Health), Yanhang Gao(Jilin University), Yi Zhou, Yawen Hao, Shijia Ling(Nanjing University of Chinese Medicine), Ningning Ma(Shenyang Pharmaceutical University), Qiuhong Zai, Junhua Zhang(Shanghai Advanced Research Institute), Yixin Li(Jinan University), Yuehua Chen(Harbin Institute of Technology), Feiyu Zhang(Hubei University of Science and Technology), M Li(Shanghai University of Traditional Chinese Medicine), Xinyi Liu(Nanjing University of Chinese Medicine), Liu Yang(Nanjing Medical University), Shujun Ge, Tao Liu(Jilin University), Niu Jq(Jilin University)
Journal of Hepatology
June 1, 2026
Cited by 0


Related Papers